Deutsche Bank’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,802
Closed -$2K 5613
2016
Q2
$2K Sell
1,802
-167,598
-99% -$145K ﹤0.01% 5111
2016
Q1
$216K Hold
169,400
﹤0.01% 3631
2015
Q4
$324K Sell
169,400
-15,200
-8% -$28.9K ﹤0.01% 3479
2015
Q3
$330K Buy
184,600
+57,700
+45% +$123K ﹤0.01% 3584
2015
Q2
$266K Buy
126,900
+120,925
+2,024% +$847K ﹤0.01% 3745
2015
Q1
$40K Buy
5,975
+5,357
+867% +$37K ﹤0.01% 4463
2014
Q4
$4K Buy
+618
New +$3.99K ﹤0.01% 5951
2014
Q2
Sell
-901
Closed -$7K 6402
2014
Q1
$7K Sell
901
-10,359
-92% -$71.4K ﹤0.01% 5129
2013
Q4
$64K Buy
11,260
+8,260
+275% +$42.3K ﹤0.01% 4248
2013
Q3
$12K Buy
+3,000
New +$11.8K ﹤0.01% 5017

Other funds holding TTHI

Deutsche Bank's TTHI Position: Q3 2016 in Review

Deutsche Bank sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 1,802 shares — an estimated $2K sold.

Deutsche Bank first reported a position in TTHI in Q3 2013 and held it in 10 quarters. The position peaked at $330K in Q3 2015. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Deutsche Bank reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Deutsche Bank sold 1,802 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $2K.
  • Deutsche Bank first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q3 2013 and held it in 10 quarters.
  • Deutsche Bank's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $330K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Deutsche Bank's 13F filing for Q3 2016, filed 14 Nov 2016.